XML 31 R4.htm IDEA: XBRL DOCUMENT v3.23.2
Condensed Consolidated Statements of Operations - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Operating expenses        
Research and development $ 11,912 $ 8,856 $ 22,789 $ 18,514
General and administrative 7,104 6,616 14,287 12,980
Total operating expenses 19,016 15,472 37,076 31,494
Other Income and Expenses [Abstract]        
Interest income 3,222 776 6,320 1,040
Other income (expense) (14) 7 (17) 2
Total other income 3,208 783 6,303 1,042
Net loss $ (15,808) $ (14,689) $ (30,773) $ (30,452)
Net loss per share attributable to common stockholders, basic (in dollars per share) $ (0.13) $ (0.12) $ (0.25) $ (0.24)
Net loss per share attributable to common stockholders, diluted (in dollars per share) $ (0.13) $ (0.12) $ (0.25) $ (0.24)
Weighted-average shares used in computing net loss per share attributable to common stockholders, basic (in shares) 124,603,181 124,494,036 124,601,762 124,456,518
Weighted-average shares used in computing net loss per share attributable to common stockholders, diluted (in shares) 124,603,181 124,494,036 124,601,762 124,456,518